Shionogi & Co., Ltd.(TYO: 4507) is a Japanese pharmaceutical company founded in 1878 and headquartered in Osaka. It is globally recognized for discovering blockbuster anti-infectives, including the HIV integrase inhibitor dolutegravir(partnered with ViiV Healthcare) and the influenza treatment baloxavir marboxil(Xofluza, partnered with Roche). While Shionogi boasts exceptional small-molecule drug discovery capabilities and generates operating margins consistently above 30%, its commercial model is heavily reliant on overseas royalty income rather than proprietary global commercial infrastructure. This leaves the company exposed to patent cliffs, particularly the approaching loss of exclusivity for dolutegravir around 2027–2028. Recent efforts to independently commercialize COVID-19 antiviral ensitrelvir(Xocova) globally faced sluggish international uptake compared to domestic sales, highlighting execution bottlenecks outside Japan. Shionogi faces persistent strategic pressure to diversify into oncology and central nervous system(CNS) disorders to offset patent expiries.
Market position and competitiors
Below is a list of articles for the company:
-
Shionogi – supply chain
Market Position and Market Share Shionogi&Co.,Ltd.(TYO:4507)is a major research-driven Japanese pharmaceutical company,historically ranking within the top 8 to 10 pharmaceutical companies in Japan by domestic prescription drug revenue and market capitalization.Globally,Shionogi holds a dominant presence in specific therapeutic niches,most notably infectious diseases(HIV,influenza,COVID-19)and central nervous system(CNS)disorders. In the global HIV integrase inhibitor market,Shionogi holds an intellectual…
-
Shionogi – business model
Corporate History Foundation and Early Growth(1878–1940s) Founded in Osaka by Gisaburo Shiono as a traditional Japanese and herbal medicine wholesale business, the company incorporated as Shionogi & Co., Ltd. in 1919. It shifted toward Western-style industrial medicine, establishing manufacturing plants and supplying vital domestic pharmaceuticals through the pre-war and wartime eras. Antibiotic Specialization and Global…